Health Sciences In The Media

UArizona Health Sciences research published as a preprint on medRxiv showed no evidence that the use of analgesics following COVID-19 vaccination had a negative effect on antibody responses.

A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work.

The UArizona Health Sciences Library, located in the College of Medicine – Tucson, is among the many libraries to frequent on campus.

Melatonin supplements are designed to mimic the effects of the hormone, boosting its levels within the body to induce sleep.

Xin Tang, a student in the Mel and Enid Zuckerman College of Public Health, is the first author on a paper that found that in patients with Type 2 diabetes, thiazolidinedione monotherapy is associated with reduced dementia risk and sulfonylurea monotherapy is associated with an increased risk compared with metformin monotherapy.

The oral potassium-competitive acid blocker vonoprazan was noninferior and superior to the proton pump inhibitor lansoprazole for erosive esophagitis, according to results of the phase 3 trial.

Researchers at the UArizona Arthritis Center are undertaking a study that seeks to identify determinants of rapid knee deterioration thanks to a $3.4 million grant from the National Institutes of Health.

Andrew Weil, MD, founder and director of the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, warns that parsley, which helps improve halitosis and is also rich in vitamin K, can interfere with blood thinners.

The identification of predictive and prognostic biomarkers has become increasingly important in the diagnosis and treatment of ovarian cancers, especially as newer biomarkers emerge.

As part of the fight against the opioid crisis, the UArizona Center for Rural Health offers free training on how to apply naloxone and what to do in an emergency.